Status:
RECRUITING
MINIject Global Long-Term Follow-up Study
Lead Sponsor:
iSTAR Medical
Conditions:
Open Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18-99 years
Brief Summary
The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a...
Detailed Description
The study aims to assess long-term safety and performance of MINIject glaucoma implant up to 5 years post-implantation. Patients who received implant and were followed for 2 years in a previous study,...
Eligibility Criteria
Inclusion
- Patient who received a MINIject glaucoma implant within a prior clinical study
- Patient continues to have MINIject implanted at the point of enrolment
- Patient must provide written informed consent to participate
Exclusion
- Individuals under tutorship or trusteeship
- Patient who is unwilling to return to the study visits and undergo study assessments, as required by clinical study protocol
Key Trial Info
Start Date :
August 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04524416
Start Date
August 5 2020
End Date
December 1 2025
Last Update
February 28 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Oftalmologica del Caribe
Barranquilla, Colombia
2
Center Hospotalier Universitaire Genoble Alpes
Grenoble, France, 38043
3
Hopital de la Croix-Rousse
Lyon, France, 69417
4
Uniklinik Köln
Cologne, North Rhine-Westphalia, Germany, 50937